Changes in Intensity of Serotonin Syndrome Caused by Adverse Interaction Between Monoamine Oxidase Inhibitors and Serotonin Reuptake Blockers

Neuropsychopharmacology - United Kingdom
doi 10.1038/npp.2014.49
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report

International Journal of Hospital Pharmacy
2017English

Selective Serotonin Reuptake Inhibitors for Fibromyalgia Syndrome

Sao Paulo Medical Journal
Medicine
2015English

Selective Serotonin Reuptake Inhibitors.

BMJ
1992English

Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?

Journal of Biomedical Science and Engineering
2018English

Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)

2012English

4 Serotonin and Reuptake Inhibitors of Biogenic Amines

2019English

Efflux Inhibition by Selective Serotonin Reuptake Inhibitors in Escherichia Coli

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2011English

Selective Serotonin Reuptake Inhibitors (SSRIs) for Stroke

2011English

Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy